Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)
Authors list
Solange Peters Urania Dafni Michael Boyer Dirk De Ruysscher Corinne Faivre-Finn Enriqueta Felip Pilar Garrido Nicolas Girard Matthias Guckenberger John Haanen Cecile Le Pechoux Francoise Mornex Mahmut Ozsahin Luis Paz-Ares David Planchard David Raben Suresh Ramalingam Martin Reck Egbert Smit Rolf Stahel Albrecht Stenzinger Charles Swanton Stefania Vallone Marina GarassinoFull text links
Publisher website (DOI) 10.1093/annonc/mdy553
Europe PubMed Central 30624547
Pubmed 30624547
Keywords
Related topics
Type of publication